Croatian skeletons reveal changing status of cancer in Europe across the centuriesJuly 06, 2004Innsbruck, Austria: Cancer incidence rates in the developed world are increasing each year and developing countries are also now showing an increased incidence of the disease. But how much were our ancestors affected by the disease? Dr Mario Slaus of the Croatian Academy of Sciences and Arts in Zagreb presented archaeological findings at the 18th Meeting of the European Association of Cancer Research (EACR-18) in Innsbruck today (6 July 2004), suggesting that the disease was very uncommon even in our recent ancestors, reinforcing the concept that cancer is a 'modern' disease and is largely a consequence of the greater longevity we are now experiencing. Dr Slaus and his colleagues1 analysed the skeletal remains of the 3,160 individuals in the Skeletal Collection of the Croatian Academy of Sciences and Arts for evidence of neoplasms (uncontrolled and abnormal tissue growth). The remains in the collection date from 5,300BC to the 19th Century AD and have been collected from archaeological sites across Croatia. Analysis (including gross morphology, X-rays and CT-scans) revealed 4 cases of neoplastic disease in individuals ranging from 3-4 years to 50-60 years of age. All 4 cases involved bone neoplasms (obviously, as bone was the only tissue remaining): two fibrous cortical defects, an osteochondroma and an osteoma. All three conditions were benign, with little potential for malignant transformation. "The low frequency of neoplasms in the Croatian Skeletal Collection is characteristic for archaeological material", said Dr Slaus. "We found no evidence of secondary bone tumours in any individual in the collection, a factor that is probably explained by the fact that the mean age-at-death of the specimens is 35.6 years. Primary malignant and benign tumours of bone are relatively rare, even in young individuals where the incidence of these neoplasms is highest, whilst secondary tumours of bone, although much more common, are associated with older age". Life expectancy in the 21st Century is higher than it has ever been in the past; a consequence of a range of factors such as better nutrition, improved health awareness in the population, better sanitation and more accessible healthcare. However, increased longevity is accompanied by an increased incidence of cancer. The factors most clearly correlated with the development of cancer in the European Union are smoking (estimated to cause 30% of all cancer deaths) and obesity / dietary factors (estimated to be responsible for a further 30% of all cancer deaths) but these factors often take many years to lead to the development of symptomatic tumours, so aging populations naturally show a higher incidence of the disease. "The individuals in the Croatian Skeletal Collection would have been prone to diseases such as syphilis, tuberculosis and leprosy (and we found evidence for each of these conditions in individuals in the collection) and these illnesses (and others) would certainly have contributed significantly to mortality in our ancestors", added Dr Slaus. "The change from these 'old' illnesses to 'modern' ones such as cancer can be seen as part of the evolution of our society, but as with the 'old' illnesses we can go some way to combating the 'modern' illness of cancer through educating people about the risks of the disease and encouraging them to adopt a healthy lifestyle", said Dr Slaus. The Croatian Skeletal Collection demonstrates how cancer is, in large part, a consequence of our recently significantly increased life-span, as well as significant changes to our lifestyle. The incidence of cancer we currently have in Europe, and the increasing incidence being seen in the developing world, can be reduced significantly through greater education about the benefits of not smoking tobacco, by encouraging people to eat a diet plentiful in fresh fruit and vegetables, through the promotion of a lifestyle that includes regular exercise and by encouraging people not to drink alcohol to excess. | |||||||||||||||||||||
|
Related Cancer Current Events and Cancer News Articles Deaths from lung cancer could be reduced by better policies to control indoor radon About 1100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com today. Protein's essential role in repairing damaged cells revealed University of Michigan researchers have discovered that a key protein in cells plays a critical role in not one, but two processes affecting the development of cancer. Interpretation Time for Screening Digital Mammograms: Is it Efficient? Digital mammograms take longer to interpret than film-screen mammograms, according to a study performed at The University of Texas M.D. Anderson Cancer Center in Houston, Texas. Scientists can now differentiate between healthy cells and cancer cells One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. Team finds breast cancer gene linked to disease spread A team of researchers at Princeton University and The Cancer Institute of New Jersey has identified a long-sought gene that is fatefully switched on in 30 to 40 percent of all breast cancer patients, spreading the disease, resisting traditional chemotherapies and eventually leading to death. New hope for cancer comes straight from the heart Digitalis-based drugs like digoxin have been used for centuries to treat patients with irregular heart rhythms and heart failure and are still in use today. In the Dec. 16 issue of the Proceedings of the National Academy of Sciences, researchers at the Johns Hopkins University School of Medicine now report that this same class of drugs may hold new promise as a treatment for cancer. Cell Biologists Identify New Tumor Suppressor for Lung Cancer Cancer and cell biology experts at the University of Cincinnati (UC) have identified a new tumor suppressor that may help scientists develop more targeted drug therapies to combat lung cancer. Errors involving medications common in outpatient cancer treatment Seven percent of adults and 19 percent of children taking chemotherapy drugs in outpatient clinics or at home were given the wrong dose or experienced other mistakes involving their medications. Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds An extract from grape seeds forces laboratory leukemia cells to commit cell suicide, according to researchers from the University of Kentucky. They found that within 24 hours, 76 percent of leukemia cells had died after being exposed to the extract. In lung cancer, silencing one crucial gene disrupts normal functioning of genome While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism. More Cancer Current Events and Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||